Camelot Portfolios’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Camelot Portfolios's LH Position: Q2 2026 in Review
Camelot Portfolios increased its Labcorp (LH) stake by 44% in Q2 2026, buying an estimated $148K and bringing the position to 1,835 shares worth $514K. The position accounts for 0.36% of the portfolio, ranked #110.
Camelot Portfolios first reported a position in LH in Q2 2018 and has held it in 28 quarters since. The position peaked at $1.12M in Q2 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Camelot Portfolios held 1,835 shares of Labcorp worth $514K as of Q2 2026.
- Camelot Portfolios bought 563 Labcorp shares in Q2 2026, an estimated $148K.
- Labcorp made up 0.36% of Camelot Portfolios's portfolio in Q2 2026, its #110 holding.
- Camelot Portfolios first reported a position in Labcorp in Q2 2018 and has held it in 28 quarters since.
- Camelot Portfolios's Labcorp position peaked at $1.12M in Q2 2021.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.